PNTG (Pennant Group) Equivalent Admissions #: 0.00 (As of Mar. 2026)


PNTG Pennant Group Inc PNTG
89 GF Score
Price $39.27
GF Value $34.66
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Pennant Group Equivalent Admissions #?

Pennant Group PNTG -1.06% 89 Equivalent Admissions # is 0.00 as of Mar. 2026. GuruFocus rates PNTG with a GF Score™ of 89/100 and a GF Value™ of $34.66 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Equivalent Admissions # are a general measure used to indicate combined inpatient and outpatient volumes.

The historical rank and industry rank for Pennant Group's Equivalent Admissions # or its related term are showing as below:

PNTG's Equivalent Admissions # is not ranked *
in the Healthcare Providers & Services industry.
Industry Median:
* Ranked among companies with meaningful Equivalent Admissions # only.

Pennant Group Equivalent Admissions # Historical Data

* Premium members only.

The historical data trend for Pennant Group's Equivalent Admissions # can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pennant Group Equivalent Admissions # Chart

Pennant Group Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Equivalent Admissions #
Get a 7-Day Free Trial Premium Member Only Premium Member Only
Average Patient Days #
Get a 7-Day Free Trial Premium Member Only Premium Member Only

Pennant GroupQuarterly Data
Trend Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Equivalent Admissions #
Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only
Average Patient Days #
Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only

PNTG vs AMN, NUTX, ARDT: Equivalent Admissions # Comparison

For the Medical Care Facilities subindustry, Pennant Group's Equivalent Admissions #, along with its competitors' market caps and Equivalent Admissions # data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PNTG
89GF Score
Pennant Group Inc PNTG
Equivalent Admissions # is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions
What does a Equivalent Admissions # of 0.00 mean?
Pennant Group (PNTG) has a Equivalent Admissions # of 0.00 as of Mar. 2026. Equivalent Admissions are a general measure used to indicate combined inpatient and outpatient volumes. View historical data on Pennant Group and its competitors.
Is Pennant Group's Equivalent Admissions # too high?
Pennant Group's current Equivalent Admissions # is 0.00. Overall, Pennant Group has a GF Score™ of 89/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pennant Group's Equivalent Admissions # compare to AMN and NUTX?
Pennant Group's Equivalent Admissions # of 0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equivalent Admissions # for a Healthcare Providers & Services company?
A good Equivalent Admissions # depends on the Healthcare Providers & Services industry context. However, Equivalent Admissions # should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equivalent Admissions # mean?
A high Equivalent Admissions # can signal that a stock is expensive relative to its fundamentals. Equivalent Admissions are a general measure used to indicate combined inpatient and outpatient volumes. View historical data on Pennant Group and its competitors. Pennant Group's current Equivalent Admissions # is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pennant Group stock overvalued right now?
Based on GuruFocus' analysis, Pennant Group (PNTG) is currently considered Modestly Overvalued. The stock's GF Value™ is $34.66, compared to a current price of $39.27 — trading 13.3% above its estimated fair value. The current Equivalent Admissions # is 0.00. Pennant Group's overall GF Score™ is 89/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equivalent Admissions # calculated?
Equivalent Admissions # is calculated from a company's financial statements. For Pennant Group (PNTG), the current Equivalent Admissions # is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pennant Group (PNTG) Overvalued in 2026?

Based on GuruFocus' analysis, Pennant Group stock appears to be overvalued. The current stock price of $39.27 is trading 13.3% above its estimated GF Value™ of $34.66. GuruFocus considers Pennant Group to be Modestly Overvalued.

Key valuation signals for PNTG:

  • Equivalent Admissions #: 0.00
  • GF Value™: $34.66 vs. price of $39.27 (13.3% above fair value)
  • GF Score™: 89/100 with 8 warning signs

No single metric tells the full story. See the PNTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pennant Group Business Description

Other Exchanges 1ZU:Germany
Address 1675 East Riverside Drive, Suite 150, Eagle, ID, USA, 83616
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
89GF Score

Get the complete analysis for PNTG

Equivalent Admissions # is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$39.27
Price
$34.66
GF Value